Guardian Pharmacy (GRDN) | Stock Overview & Key Data
Guardian Pharmacy Performance Comparison
Stock Range
Today's Range
Low: $25.47
High: $26.70
on August 21, 2025
52 Week Range
Low: $14.16
High: $26.91
on September 26, 2024
on May 7, 2025
All-Time High: $26.91 on May 5, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.6B
EPS
-1.48
P/E Ratio (TTM)
90.13
Forward P/E
28.59
P/B Ratio
9.28
PEG Ratio
-6.39
Div. Yield
N/A
ROE
-52.74%
Beta
N/A
Debt to Equity
22.18
Financial Highlights
Profitability
Gross Margin
19.79%
Operating Margin
4.38%
Profit Margin
-5.19%
Returns and Earnings
Return on Assets (TTM)
-10.92%
Return on Equity (TTM)
-52.74%
EBITDA
$-36.9M
Net Income (TTM)
$-91.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$20.96
Quarterly Revenue Growth (YoY)
14.80%
Quarterly Earnings Growth (YoY)
-15.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Guardian Pharmacy GRDN | 1.57B Small-cap | 10.05% | 25.85% | 19.17% | 34.27% | 32.18% | 48.11% | 48.11% | 48.11% |
| HCA Healthcare HCA | 94.23B Large-cap | 2.70% | 10.89% | 5.88% | 27.76% | 35.77% | 3.98% | 97.22% | 197.27% |
| Tenet Healthcare THC | 15.73B Large-cap | 2.92% | 1.57% | 8.94% | 36.88% | 41.66% | 7.82% | 195.31% | 515.72% |
| Acadia Healthcare ACHC | 1.94B Small-cap | 3.68% | -1.02% | -8.89% | -45.98% | -47.46% | -73.19% | -74.08% | -31.41% |
| Select Medical SEM | 1.85B Small-cap | 3.10% | -10.48% | -11.93% | -26.53% | -30.87% | -32.24% | -9.03% | 18.31% |
| Pacs PACS | 1.84B Small-cap | 1.73% | 0.95% | 18.72% | -8.29% | -9.28% | -71.61% | -51.13% | -51.13% |
Ownership & Short Interest
Insider Ownership
15.09%
Institutional Ownership
83.26%
Shares Short
515K
Short Ratio
3.03
Short % of Shares Outstanding
4.09%
Average 10-Day Volume
225K
Average 90-Day Volume
158K
Guardian Pharmacy Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Guardian Pharmacy would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GRDN's 52-week high and low?
- In the last 52 weeks, Guardian Pharmacy reached a high of $26.91 (on May 7, 2025) and a low of $14.16 (on September 26, 2024).
- What is the market cap and P/E ratio for GRDN?
- Curious about Guardian Pharmacy's size and valuation? Its market capitalization stands at 1.57B. When it comes to valuation, the P/E ratio (trailing twelve months) is 90.13, and the forward P/E (looking ahead) is 28.59.
- Does GRDN pay dividends? If so, what's the yield?
- As for dividends, Guardian Pharmacy isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Guardian Pharmacy's main competitors or similar companies to consider before investing?
When looking at Guardian Pharmacy, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA94.23B Healthcare Medical Care Facilities 3.98% 97.22% Tenet Healthcare
THC15.73B Healthcare Medical Care Facilities 7.82% 195.31% Acadia Healthcare
ACHC1.94B Healthcare Medical Care Facilities -73.19% -74.08% Select Medical
SEM1.85B Healthcare Medical Care Facilities -32.24% -9.03% Pacs
PACS1.84B Healthcare Medical Care Facilities -71.61% -51.13% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Guardian Pharmacy Services Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Guardian Pharmacy's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -52.74%, the Debt to Equity ratio from the most recent quarter is 22.18, and its Gross Profit Margin stands at 19.79%.
- What is the recent revenue and earnings growth for GRDN?
- Looking at Guardian Pharmacy's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.80%, and quarterly earnings saw a YoY growth of -15.00%.
- How much of GRDN stock is held by insiders and institutions?
- Wondering who owns Guardian Pharmacy stock? Company insiders (like executives and directors) hold about 15.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 83.26%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.